MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test sale cost 2310 AED
Diabetes Type 1 Autoimmune Profile Test sale cost 2460 AED Diabetes Type 1 Autoimmune Profile Test Cost 2,730 د.إ Original price was: 2,730 د.إ.2,460 د.إCurrent price is: 2,460 د.إ.
Hepatitis B Viral Drug Resistance and Genotyping Test sale cost 2340 AED Hepatitis B Viral Drug Resistance and Genotyping Test Cost 2,600 د.إ Original price was: 2,600 د.إ.2,340 د.إCurrent price is: 2,340 د.إ.
Sale!

MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test Cost

Original price was: 2,720 د.إ.Current price is: 2,310 د.إ.

-15%

The “MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test” is a sophisticated diagnostic tool used to identify and differentiate the RNA of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in patients. This test specifically targets the upstream EORF1a and ORF1b regions of the virus’s genome, employing a multiplex approach that allows for the simultaneous detection of both genetic markers. This method ensures a high level of accuracy and specificity in diagnosing MERS-CoV, which is crucial for timely patient management and containment of the virus spread.

The test is conducted at DNA Labs UAE, a leading facility in the field of molecular diagnostics and genetic testing. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in virology and molecular biology, ensuring reliable and accurate test results.

The cost of the test is set at 2310 AED, reflecting the complexity of the technology used and the expertise required to perform the analysis. Despite the cost, the test provides critical information for the effective treatment and control of MERS, a potentially deadly respiratory illness that has been a significant health concern in the Middle East and beyond.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test

Test Name: MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test

Components: Sputum, throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures, Respiratory swab, and endotracheal aspirate material, serum stool and feces, ETC

Price: 2310.0 AED

Report Delivery: 4th Working Day Email: 48 hours. On phone: 36 hours

Method: Real Time PCR

Test type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Need to sign Consent document and bring any clinical history of patient for MERS (Middle East Respiratory Syndrome) (UpE, ORF1a & ORF1b) Multiplex Detection and Differentiation (RNA Detection) Qualitative Test

Test Details

The MERS (Middle East Respiratory Syndrome) (UpE, ORF1a & ORF1b) Multiplex Detection and Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate the Middle East Respiratory Syndrome (MERS) virus.

MERS is a viral respiratory illness caused by the MERS-CoV (Middle East Respiratory Syndrome Coronavirus). This test specifically targets three regions of the MERS-CoV genome, namely UpE, ORF1a, and ORF1b. By detecting the presence of viral RNA in a patient’s sample, the test can determine if the patient is infected with the MERS-CoV.

The test is performed using a multiplex detection method, which means it can simultaneously detect multiple target regions of the viral genome. This allows for a more accurate and efficient diagnosis. The test is qualitative, meaning it can determine the presence or absence of the virus in the patient’s sample, but it cannot quantify the viral load.

Overall, the MERS (UpE, ORF1a & ORF1b) Multiplex Detection and Differentiation (RNA Detection) Qualitative Test is an important tool in the diagnosis and surveillance of MERS-CoV infections. It helps healthcare professionals identify and differentiate MERS cases from other respiratory illnesses, allowing for appropriate patient management and control measures to be implemented.

Test Name MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test
Components
Price 2310.0 AED
Sample Condition Sputum, throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures, Respiratory swab,and endotracheal aspirate material ,serum stool and feces,ETC
Report Delivery 4th Working Day Email : 48 hours.On phone : 36 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forMERS (Middle East Respiratory Syndrome) (UpE,ORF1a & ORF1b) Multiplex Detection and Differentiation (RNA Detection) QualitativeTest
Test Details

The MERS (Middle East Respiratory Syndrome) (UpE, ORF1a & ORF1b) Multiplex Detection and Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate the Middle East Respiratory Syndrome (MERS) virus.

MERS is a viral respiratory illness caused by the MERS-CoV (Middle East Respiratory Syndrome Coronavirus). This test specifically targets three regions of the MERS-CoV genome, namely UpE, ORF1a, and ORF1b. By detecting the presence of viral RNA in a patient’s sample, the test can determine if the patient is infected with the MERS-CoV.

The test is performed using a multiplex detection method, which means it can simultaneously detect multiple target regions of the viral genome. This allows for a more accurate and efficient diagnosis. The test is qualitative, meaning it can determine the presence or absence of the virus in the patient’s sample, but it cannot quantify the viral load.

Overall, the MERS (UpE, ORF1a & ORF1b) Multiplex Detection and Differentiation (RNA Detection) Qualitative Test is an important tool in the diagnosis and surveillance of MERS-CoV infections. It helps healthcare professionals identify and differentiate MERS cases from other respiratory illnesses, allowing for appropriate patient management and control measures to be implemented.

SKU: TEST-4911